₹ 14868 / 14 Shares Shares
Minimum Investment
₹1008-1062 per equity share
08 Dec 2025
10 Dec 2025
14
₹ 14868
₹1008-1062
15 Dec 2025
61,71,101 shares(aggregating up to ₹655.37 crore)
₹10 Per Equity Share
14 Shares
14 Shares
Incorporated in August 2004, Corona Remedies Limited is a pharmaceutical company developing, manufacturing, and marketing products in women's healthcare, cardiology, pain management, urology, and other therapeutic areas. The diversified portfolio of the company as of December 2024 comprises 67 brands across therapeutic areas such as women's healthcare, cardio-diabeto, pain management, urology, and multispecialty pharmaceuticals, including vitamins/minerals/nutrition, gastrointestinal, and respiratory.The company has a pan-India marketing and distribution network with 2,598 medical representatives in 22 states, enabling effective engagement with healthcare professionals and hospitals, thus consolidating its presence in the IPM and ensuring deep penetration in therapeutic areas. Presently, the company owns two manufacturing facilities located in the states of Gujarat. As of December 31, 2024, the company had 88 R&D employees.
2004
Dr. Kirtikumar Laxmidas Mehta
Corona Remedies Limited IPO
| Apply as | Price Range | Apply Upto |
|---|---|---|
| Retail (min) | ₹1008-1062 | ₹14,868 |
| Retail(max) | ₹1008-1062 | ₹1,93,284 |
| SHNI(min) | ₹1008-1062 | ₹2,08,152 |
| SHNI(max) | ₹1008-1062 | ₹9,96,156 |
| BHNI(min) | ₹1008-1062 | ₹10,11,024 |
For Corona Remedies Limited IPO, eligible investors can apply as Regular.
Unlike existing funds with track records, NFOs offer fresh investment opportunities, often at a face value of ₹10.
KSquare simplifies the process by partnering with lenders and offering a smooth, digital journey from application to disbursal.
NPS is regulated by PFRDA and offers transparency, safety, and steady growth through professional fund managers.
KSquare’s online dashboard lets NRIs monitor and manage portfolios 24/7, no matter where they are in the world.
Mutual funds pool money from many investors to invest in a diversified portfolio of stocks, bonds, or other assets managed by professionals.
Yes, you can set up multiple SIPs with KSquare for various goals like retirement, education, or buying a home.
Mutual funds may have expense ratios and exit loads. KSquare discloses all charges clearly before you invest.
Absolutely! SIPs are ideal for beginners due to their simplicity, flexibility, and potential for long-term wealth creation.
Ksquare Timeline Pvt. Ltd. is an AMFI Registered Mutual Fund Distributor having ARN No. 146262. Mutual Fund investments are subject to market risks. Please read all scheme related documents carefully before investing. This website is intended only for informational and self-help purposes and should not be considered as investment advice or return guarantee. Past performance is not indicative of future results. Terms & Conditions apply.